NurOwn

Related by string. * * NurOwn tm technology . NurOwn ™ . NurOwn TM patent . NurOwn TM *

Related by context. Frequent words. (Click for all words.) 68 ZFP Therapeutics 64 immunotherapeutics 64 Initiates Phase II 64 Neogenix 63 Sangamo ZFP technology 63 novel RNAi therapeutics 63 theranostic 63 Ibis T# 62 therapeutic monoclonal antibodies 62 regarding Aethlon Medical 62 MVA BN R 62 personalized immunotherapy 62 optical biosensors 62 Completes Patient Enrollment 62 Thiarabine 62 Antigen Express comprise immunotherapeutics 62 Hepatitis C Virus HCV 62 GammaCan 62 malignant infectious 62 KL4 surfactant 62 Xanafide 62 Onconase 62 TELINTRA 62 ATL# [001] 61 ViaCyte 61 novel anti infective 61 bio therapeutics 61 Prodarsan ® 61 inflammatory autoimmune diseases 61 Optimata 61 non personalized allogeneic 61 MassARRAY R 61 Factor VIIa 61 Litx 61 Ampligen ® 61 Electroporation 61 liposomal formulation 61 BiTE R 61 photodisinfection 61 Receives Orphan Drug Designation 61 ALN TTR# 61 commercializing therapeutic 61 siRNA therapeutic 61 Aerosurf 60 GVAX cancer 60 Onalta 60 autologous cell 60 MultiCell Technologies 60 Vivecon 60 New Chemical Entities 60 MEK inhibitors 60 MAXY G# 60 autologous adult 60 Tissue Repair Company 60 Recombinant Human 60 SNALP 60 molecular biomarkers 60 topically delivered 60 JAK1 60 Fortical R 60 Protein Therapeutics 60 BioSilicon TM 60 NEUMUNE 60 oncolytic virus 60 preclinical efficacy 60 AutovaxID 60 DermaVir 60 Affymetrix GeneChip ® 60 StromaCel Inc. 60 therapeutic modality 60 orally bioavailable 60 Chemokine Therapeutics 60 HepeX B 60 leading lipid nanoparticle 59 huC# DM4 59 Lipid Polymer Micelle LPM 59 ISTO 59 AAV vector 59 iPSC 59 Daclizumab 59 Avicena 59 AAV vectors 59 iPSC technology 59 proprietary Mimetic Ligand 59 TLR9 agonists 59 Pervasis 59 Azedra 59 targeting CD# 59 Panzem R 59 HepaLife Technologies Inc. 59 Phase IIb clinical trials 59 Hemopurifier TM 59 novel anticancer 59 VALSTAR 59 AzaSite Plus 59 GlycosBio 59 Hybridon 59 Cobalamin 59 Oncaspar 59 TLR9 agonist 59 systemic fungal infections

Back to home page